PYRAZINAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USES THEREOF AS TYK2 INHIBITOR
The present invention provides a pyridazine compound as shown in formula (II), a preparation method therefor, and uses thereof. Also disclosed are uses of the compound of the present invention or the pharmaceutical composition thereof in preparation of a medicine for preventing and/or treating TYK2-...
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | XU, Xin ZHANG, Xiaojuan LI, Qiang LI, Xianni ZHOU, Xiaobo JIANG, Xiangmei GUO, Fengying CHEN, Jia |
description | The present invention provides a pyridazine compound as shown in formula (II), a preparation method therefor, and uses thereof. Also disclosed are uses of the compound of the present invention or the pharmaceutical composition thereof in preparation of a medicine for preventing and/or treating TYK2-mediated diseases.
La présente invention concerne un composé pyridazine tel que représenté dans la formule (II), son procédé de préparation et ses utilisations. L'invention concerne également des utilisations du composé de la présente invention ou de la composition pharmaceutique à base de celui-ci dans la préparation d'un médicament pour la prévention et/ou le traitement de maladies médiées par la TYK2.
本发明提供了式(Ⅱ)所示的哒嗪类化合物、其制备方法和用途。本发明还公开了本发明化合物或其药物组合物在制备用于预防和/或治疗TYK2介导的疾病的药物中的用途。 |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2024088282A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2024088282A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2024088282A13</originalsourceid><addsrcrecordid>eNrjZIgNiAxyjPL0c_T1dHFVcPb3DfAP9XPRUQjwcAzydXR2DQ3xdHb0gUgEe4Z4-vsphHi4Brn6u-koOPq5KIQGuwbDRBQcgcxIbyMFTz8PTyfPEP8gHgbWtMSc4lReKM3NoOzmGuLsoZtakB-fWlyQmJyal1oSH-5vZGBkYmBhYWRh5GhoTJwqANPUM7A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PYRAZINAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USES THEREOF AS TYK2 INHIBITOR</title><source>esp@cenet</source><creator>XU, Xin ; ZHANG, Xiaojuan ; LI, Qiang ; LI, Xianni ; ZHOU, Xiaobo ; JIANG, Xiangmei ; GUO, Fengying ; CHEN, Jia</creator><creatorcontrib>XU, Xin ; ZHANG, Xiaojuan ; LI, Qiang ; LI, Xianni ; ZHOU, Xiaobo ; JIANG, Xiangmei ; GUO, Fengying ; CHEN, Jia</creatorcontrib><description>The present invention provides a pyridazine compound as shown in formula (II), a preparation method therefor, and uses thereof. Also disclosed are uses of the compound of the present invention or the pharmaceutical composition thereof in preparation of a medicine for preventing and/or treating TYK2-mediated diseases.
La présente invention concerne un composé pyridazine tel que représenté dans la formule (II), son procédé de préparation et ses utilisations. L'invention concerne également des utilisations du composé de la présente invention ou de la composition pharmaceutique à base de celui-ci dans la préparation d'un médicament pour la prévention et/ou le traitement de maladies médiées par la TYK2.
本发明提供了式(Ⅱ)所示的哒嗪类化合物、其制备方法和用途。本发明还公开了本发明化合物或其药物组合物在制备用于预防和/或治疗TYK2介导的疾病的药物中的用途。</description><language>chi ; eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240502&DB=EPODOC&CC=WO&NR=2024088282A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240502&DB=EPODOC&CC=WO&NR=2024088282A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>XU, Xin</creatorcontrib><creatorcontrib>ZHANG, Xiaojuan</creatorcontrib><creatorcontrib>LI, Qiang</creatorcontrib><creatorcontrib>LI, Xianni</creatorcontrib><creatorcontrib>ZHOU, Xiaobo</creatorcontrib><creatorcontrib>JIANG, Xiangmei</creatorcontrib><creatorcontrib>GUO, Fengying</creatorcontrib><creatorcontrib>CHEN, Jia</creatorcontrib><title>PYRAZINAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USES THEREOF AS TYK2 INHIBITOR</title><description>The present invention provides a pyridazine compound as shown in formula (II), a preparation method therefor, and uses thereof. Also disclosed are uses of the compound of the present invention or the pharmaceutical composition thereof in preparation of a medicine for preventing and/or treating TYK2-mediated diseases.
La présente invention concerne un composé pyridazine tel que représenté dans la formule (II), son procédé de préparation et ses utilisations. L'invention concerne également des utilisations du composé de la présente invention ou de la composition pharmaceutique à base de celui-ci dans la préparation d'un médicament pour la prévention et/ou le traitement de maladies médiées par la TYK2.
本发明提供了式(Ⅱ)所示的哒嗪类化合物、其制备方法和用途。本发明还公开了本发明化合物或其药物组合物在制备用于预防和/或治疗TYK2介导的疾病的药物中的用途。</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZIgNiAxyjPL0c_T1dHFVcPb3DfAP9XPRUQjwcAzydXR2DQ3xdHb0gUgEe4Z4-vsphHi4Brn6u-koOPq5KIQGuwbDRBQcgcxIbyMFTz8PTyfPEP8gHgbWtMSc4lReKM3NoOzmGuLsoZtakB-fWlyQmJyal1oSH-5vZGBkYmBhYWRh5GhoTJwqANPUM7A</recordid><startdate>20240502</startdate><enddate>20240502</enddate><creator>XU, Xin</creator><creator>ZHANG, Xiaojuan</creator><creator>LI, Qiang</creator><creator>LI, Xianni</creator><creator>ZHOU, Xiaobo</creator><creator>JIANG, Xiangmei</creator><creator>GUO, Fengying</creator><creator>CHEN, Jia</creator><scope>EVB</scope></search><sort><creationdate>20240502</creationdate><title>PYRAZINAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USES THEREOF AS TYK2 INHIBITOR</title><author>XU, Xin ; ZHANG, Xiaojuan ; LI, Qiang ; LI, Xianni ; ZHOU, Xiaobo ; JIANG, Xiangmei ; GUO, Fengying ; CHEN, Jia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2024088282A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng ; fre</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>XU, Xin</creatorcontrib><creatorcontrib>ZHANG, Xiaojuan</creatorcontrib><creatorcontrib>LI, Qiang</creatorcontrib><creatorcontrib>LI, Xianni</creatorcontrib><creatorcontrib>ZHOU, Xiaobo</creatorcontrib><creatorcontrib>JIANG, Xiangmei</creatorcontrib><creatorcontrib>GUO, Fengying</creatorcontrib><creatorcontrib>CHEN, Jia</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>XU, Xin</au><au>ZHANG, Xiaojuan</au><au>LI, Qiang</au><au>LI, Xianni</au><au>ZHOU, Xiaobo</au><au>JIANG, Xiangmei</au><au>GUO, Fengying</au><au>CHEN, Jia</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PYRAZINAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USES THEREOF AS TYK2 INHIBITOR</title><date>2024-05-02</date><risdate>2024</risdate><abstract>The present invention provides a pyridazine compound as shown in formula (II), a preparation method therefor, and uses thereof. Also disclosed are uses of the compound of the present invention or the pharmaceutical composition thereof in preparation of a medicine for preventing and/or treating TYK2-mediated diseases.
La présente invention concerne un composé pyridazine tel que représenté dans la formule (II), son procédé de préparation et ses utilisations. L'invention concerne également des utilisations du composé de la présente invention ou de la composition pharmaceutique à base de celui-ci dans la préparation d'un médicament pour la prévention et/ou le traitement de maladies médiées par la TYK2.
本发明提供了式(Ⅱ)所示的哒嗪类化合物、其制备方法和用途。本发明还公开了本发明化合物或其药物组合物在制备用于预防和/或治疗TYK2介导的疾病的药物中的用途。</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | chi ; eng ; fre |
recordid | cdi_epo_espacenet_WO2024088282A1 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | PYRAZINAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USES THEREOF AS TYK2 INHIBITOR |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T21%3A43%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=XU,%20Xin&rft.date=2024-05-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2024088282A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |